Newborn screening alone insufficient to improve pulmonary outcomes for cystic fibrosis.
primary studies published, non RCT
Details- 2021
- Barreda CB
Maternal and fetal outcomes following elexacaftor-tezacaftor-ivacaftor use during pregnancy and lactation.
primary studies published, non RCT
Details- 2021
- Taylor-Cousar JL
Lumacaftor/ivacaftor in cystic fibrosis: effects on glucose metabolism and insulin secretion.
primary studies published, non RCT
Details- 2021
- Colombo C
Clinical Effectiveness of Elexacaftor/Tezacftor/Ivacaftor in People with Cystic Fibrosis.
primary studies published, non RCT
Details- 2021
- Nichols DP
The long-term safety of chronic azithromycin use in adult patients with cystic fibrosis, evaluating biomarkers for renal function, hepatic function and electrical properties of the heart.
primary studies published, non RCT
Details- 2021
- Akkerman-Nijland AM
Change in Nutrient and Dietary Intake in European Children with Cystic Fibrosis after a 6-Month Intervention with a Self-Management mHealth Tool.
primary studies published, non RCT
Details- 2021
- Calvo-Lerma J
Association Between Transient Elastography and Controlled Attenuated Parameter and Liver Ultrasound in Children With Cystic Fibrosis.
primary studies published, non RCT
Details- 2021
- Ye W
The impact of chest computed tomography and chest radiography on clinical management of cystic fibrosis lung disease.
primary studies published, non RCT
Details- 2020
- Bortoluzzi CF
Cystic Fibrosis: A Simple and Customized Strategy for Genetic Screening Able to Detect Over 90% of Identified Mutated Alleles in Brazilian Newborns.
primary studies published, non RCT
Details- 2020
- Rispoli T
Mechanisms of action of a web-based intervention with health professional support to increase nebulizer adherence in adults with Cystic Fibrosis: a qualitative interview study.
primary studies published, non RCT
Details- 2020
- Drabble S